Skip to main content

Tarsus Pharmaceuticals, Inc 10-Q for FY2022 Q1

Tarsus Pharmaceuticals, Inc. (TARS)

10-Q 2022-05-11 For: 2022-03-31
View Original
Added on April 04, 2026

About this 10-Q

Tarsus Pharmaceuticals, Inc filed this 10-Q on May 11, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).

Headline figures

Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$539K
down 98.4% from $33.43M a year earlier
Net loss
$20.24M
compared with net income of $10.38M a year earlier
Diluted EPS
-$0.98
compared with $0.47 a year earlier